ICU Medical, Inc. (ICUI)
125.36
-1.27
(-1.00%)
USD |
NASDAQ |
Mar 20, 16:00
126.24
+0.88
(+0.70%)
After-Hours: 20:00
ICU Medical Research and Development Expense (Quarterly) : 21.09M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 46.07M |
| Baxter International, Inc. | 116.00M |
| Integra LifeSciences Holdings Corp. | 7.741M |
| InfuSystem Holdings, Inc. | -- |
| iRhythm Holdings, Inc. | 21.05M |